Detailed Quote:OSTK OVERSTOCK COM INC 56.30Up 3.15 (5.93

New Post Public Reply Private Reply Replies (1) Message Board
4kids 4kids #41
512
Detailed Quote:OSTK
OVERSTOCK COM INC
56.30Up 3.15 (5.93 %)AS OF 4:00:00PM ET 11/13/2017


Last Trade 56.30
Trade Time 4:00:00pm ET

Change 3.15
% Change 5.93%


Open 52.15
Day High 56.95 ***
Day Low 51.60
Previous Close
11/10/2017 53.15

52-Week High ***
11/13/2017 56.95

52-Week Low
05/31/2017 13.75


Price Performance (Last 52 Weeks)
11/10/2017 +222.12%


Volume 3,730,662
Volume (10 day Average) 3,457,224
Volume (90 day Average) 1,169,490


Market Capitalization $1.33B
Shares Outstanding 25,023,000

OVERSTOCK.COM Incorporated
$ 56.45
OSTK
3.30
Short Squeeze Ranking™
view
Daily Short Sale Volume
view
Daily Naked Short Selling List
view
Short Interest (Shares Short)
5,166,900
Short Interest Ratio (Days To Cover)
1.6
Short Percent of Float
47.35 %
Short % Increase / Decrease
108 %
Short Interest (Shares Short) - Prior
2,480,000
Shares Float
10,913,000
Trading Volume - Today
2,567,905
Trading Volume - Average
3,232,400
Trading Volume - Today vs. Average
79.44%
% Owned by Insiders
36.77%
% Owned by Institutions
47.30%
Earnings Per Share
0
PE Ratio
67
Market Cap.
$ 1,407,863,000
% From 52-Wk High
-2.13%
% From 52-Wk Low
% From 200-Day MA
123.79%
% From 50-Day MA
50.90%
Sector
Services
Industry
Catalog & Mail Order Houses
Exchange
NAS
Record Date
2017-NovA

Beyond, Inc. (BYON) Stock Research Links

BYON Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 14

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 11

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 17

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 24

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 27

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 22

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 22

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Thermo Fisher's Role as the Leading Partner in Biopharma

Updated Category News Views 212

Thermo Fisher's Role in Revolutionizing Biopharma Thermo Fisher Scientific Inc. (TMO) is increasingly becoming the cornerstone of the biopharma sector. Although some analysts have observed a recent dip in its stock performance, there is a strong belief in its capability to rebound through strategic acquisitions and promising growth prospects. Notably, Thermo Fisher boasts...

Continue Reading
Jamf Unveils Comprehensive Reinvestment Strategy for Growth

Updated Category News Views 161

Jamf's Strategic Reinvestment Initiative In a bold move aimed at enhancing operational efficiency and shareholder value, Jamf (NASDAQ: JAMF) has announced a strategic reinvestment plan designed to propel long-term growth. This initiative comes on the heels of a comprehensive systems update that has illuminated new business opportunities and operational insights. Enhancing...

Continue Reading
Fidelity D & D Bancorp, Inc. Sees Earnings Impact in Q3

Updated Category News Views 46

Fidelity D & D Bancorp, Inc. Announcements on Financial Standing In recent news regarding Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC), the company revealed its latest financial results, marking a significant quarter in their ongoing operations. As of September 30, 2024, Fidelity Bank, under the leadership of President and CEO Daniel J. Santaniello, has recorded key...

Continue Reading
Deutsche Bank Lowers Boeing Price Target, Retains Buy Rating

Updated Category News Views 71

Deutsche Bank's Strategic Assessment of Boeing Recently, Deutsche Bank has made headlines with its updated financial outlook for Boeing (NYSE: BA), decreasing the stock price target from $225.00 to $195.00. However, they have maintained a Buy rating on the aerospace company's shares. This adjustment comes in response to expected larger free cash flow (FCF) burn for the...

Continue Reading
TIGRIS Aquatic Services Expands With LakePro Acquisition

Updated Category News Views 868

TIGRIS Aquatic Services Expands With LakePro Acquisition TIGRIS Aquatic Services, LLC has made a significant move by acquiring LakePro, Inc., a prominent player in the field of aquatic management. This acquisition opens new opportunities for TIGRIS, expanding its operational reach into fresh markets and reinforcing its commitment to creating safe and well-managed water...

Continue Reading